Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11397808rdf:typepubmed:Citationlld:pubmed
pubmed-article:11397808lifeskim:mentionsumls-concept:C0019704lld:lifeskim
pubmed-article:11397808lifeskim:mentionsumls-concept:C1622204lld:lifeskim
pubmed-article:11397808lifeskim:mentionsumls-concept:C0205103lld:lifeskim
pubmed-article:11397808lifeskim:mentionsumls-concept:C1332714lld:lifeskim
pubmed-article:11397808lifeskim:mentionsumls-concept:C0332466lld:lifeskim
pubmed-article:11397808lifeskim:mentionsumls-concept:C1444748lld:lifeskim
pubmed-article:11397808lifeskim:mentionsumls-concept:C1704241lld:lifeskim
pubmed-article:11397808pubmed:issue32lld:pubmed
pubmed-article:11397808pubmed:dateCreated2001-8-6lld:pubmed
pubmed-article:11397808pubmed:abstractTextAn early step in the process of HIV-1 entry into target cells is the activation of its envelope glycoprotein (GP120-GP41) to a fusogenic state upon binding to target cell CD4 and cognate co-receptor. Incubation of human immunodeficiency virus (HIV)-1 Env-expressing cells with an excess of CD4 and co-recepeptor-bearing target cells resulted in an influx of an impermeant nucleic acid-staining fluorescent dye into the Env-expressing cells. The dye influx occurred concomitant with cell fusion. No influx of dye into target cells was observed if they were incubated with an excess of Env-expressing cells. The permeabilization of Env-expressing cells was also triggered by CD4.co-receptor complexes attached to Protein G-Sepharose beads in the absence of target cells. The CD4 and co-receptor-induced permeabilization of Env-expressing cells occurred with the same specificity with respect to co-receptor usage as cell fusion. Natural ligands for the co-receptors and C-terminal GP41 peptide inhibitors of HIV-1 fusion blocked this effect. Our results indicate that the process of HIV-1 Env-mediated fusion is initiated by the destabilization of HIV-1 Env-expressing membranes. Further elucidation of these early intermediates may help identify and develop potential inhibitors of HIV-1 entry into cells.lld:pubmed
pubmed-article:11397808pubmed:languageenglld:pubmed
pubmed-article:11397808pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11397808pubmed:citationSubsetIMlld:pubmed
pubmed-article:11397808pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11397808pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11397808pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11397808pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11397808pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11397808pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11397808pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11397808pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11397808pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11397808pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11397808pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11397808pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11397808pubmed:statusMEDLINElld:pubmed
pubmed-article:11397808pubmed:monthAuglld:pubmed
pubmed-article:11397808pubmed:issn0021-9258lld:pubmed
pubmed-article:11397808pubmed:authorpubmed-author:BlumenthalRRlld:pubmed
pubmed-article:11397808pubmed:authorpubmed-author:XiaoXXlld:pubmed
pubmed-article:11397808pubmed:authorpubmed-author:DimitrovD SDSlld:pubmed
pubmed-article:11397808pubmed:authorpubmed-author:DimitrovA SASlld:pubmed
pubmed-article:11397808pubmed:issnTypePrintlld:pubmed
pubmed-article:11397808pubmed:day10lld:pubmed
pubmed-article:11397808pubmed:volume276lld:pubmed
pubmed-article:11397808pubmed:ownerNLMlld:pubmed
pubmed-article:11397808pubmed:authorsCompleteYlld:pubmed
pubmed-article:11397808pubmed:pagination30335-41lld:pubmed
pubmed-article:11397808pubmed:dateRevised2005-11-17lld:pubmed
pubmed-article:11397808pubmed:meshHeadingpubmed-meshheading:11397808...lld:pubmed
pubmed-article:11397808pubmed:meshHeadingpubmed-meshheading:11397808...lld:pubmed
pubmed-article:11397808pubmed:meshHeadingpubmed-meshheading:11397808...lld:pubmed
pubmed-article:11397808pubmed:meshHeadingpubmed-meshheading:11397808...lld:pubmed
pubmed-article:11397808pubmed:meshHeadingpubmed-meshheading:11397808...lld:pubmed
pubmed-article:11397808pubmed:meshHeadingpubmed-meshheading:11397808...lld:pubmed
pubmed-article:11397808pubmed:meshHeadingpubmed-meshheading:11397808...lld:pubmed
pubmed-article:11397808pubmed:meshHeadingpubmed-meshheading:11397808...lld:pubmed
pubmed-article:11397808pubmed:meshHeadingpubmed-meshheading:11397808...lld:pubmed
pubmed-article:11397808pubmed:meshHeadingpubmed-meshheading:11397808...lld:pubmed
pubmed-article:11397808pubmed:meshHeadingpubmed-meshheading:11397808...lld:pubmed
pubmed-article:11397808pubmed:meshHeadingpubmed-meshheading:11397808...lld:pubmed
pubmed-article:11397808pubmed:meshHeadingpubmed-meshheading:11397808...lld:pubmed
pubmed-article:11397808pubmed:meshHeadingpubmed-meshheading:11397808...lld:pubmed
pubmed-article:11397808pubmed:meshHeadingpubmed-meshheading:11397808...lld:pubmed
pubmed-article:11397808pubmed:meshHeadingpubmed-meshheading:11397808...lld:pubmed
pubmed-article:11397808pubmed:meshHeadingpubmed-meshheading:11397808...lld:pubmed
pubmed-article:11397808pubmed:meshHeadingpubmed-meshheading:11397808...lld:pubmed
pubmed-article:11397808pubmed:meshHeadingpubmed-meshheading:11397808...lld:pubmed
pubmed-article:11397808pubmed:meshHeadingpubmed-meshheading:11397808...lld:pubmed
pubmed-article:11397808pubmed:meshHeadingpubmed-meshheading:11397808...lld:pubmed
pubmed-article:11397808pubmed:meshHeadingpubmed-meshheading:11397808...lld:pubmed
pubmed-article:11397808pubmed:meshHeadingpubmed-meshheading:11397808...lld:pubmed
pubmed-article:11397808pubmed:meshHeadingpubmed-meshheading:11397808...lld:pubmed
pubmed-article:11397808pubmed:year2001lld:pubmed
pubmed-article:11397808pubmed:articleTitleEarly intermediates in HIV-1 envelope glycoprotein-mediated fusion triggered by CD4 and co-receptor complexes.lld:pubmed
pubmed-article:11397808pubmed:affiliationLaboratory of Experimental and Computational Biology, Center for Cancer Research, NCI, National Institutes of Health, Frederick, Maryland 21702, USA.lld:pubmed
pubmed-article:11397808pubmed:publicationTypeJournal Articlelld:pubmed
entrez-gene:920entrezgene:pubmedpubmed-article:11397808lld:entrezgene
entrez-gene:1234entrezgene:pubmedpubmed-article:11397808lld:entrezgene
entrez-gene:7852entrezgene:pubmedpubmed-article:11397808lld:entrezgene
entrez-gene:155971entrezgene:pubmedpubmed-article:11397808lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:11397808lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:11397808lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:11397808lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:11397808lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:11397808lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:11397808lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11397808lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11397808lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11397808lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11397808lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11397808lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11397808lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11397808lld:pubmed